[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives

H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced Drug Delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …

Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand

AO Elzoghby, MA Abdelmoneem, IA Hassanin… - Biomaterials, 2020 - Elsevier
Recent progress in protein-based nanomedicine, inspired by the success of Abraxane®
albumin-paclitaxel nanoparticles, have resulted in novel therapeutics used for treatment of …

Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)

S Kumari, SM Ahsan, JM Kumar, AK Kondapi… - Scientific reports, 2017 - nature.com
Targeted delivery of drugs to the brain is challenging due to the restricted permeability
across the blood brain barrier (BBB). Gliomas are devastating cancers and their positive …

Dual and multi-targeted nanoparticles for site-specific brain drug delivery

Y Luo, H Yang, YF Zhou, B Hu - Journal of Controlled Release, 2020 - Elsevier
In recent years, nanomedicines have emerged as a promising method for central nervous
system drug delivery, enabling the drugs to overcome the blood-brain barrier and …

[HTML][HTML] Nano-scale drug delivery systems for carboplatin: a comprehensive review

M Pourmadadi, MM Eshaghi, M Shaghaghi, SS Das… - OpenNano, 2023 - Elsevier
Carboplatin (CRBP) is a chemotherapeutic agent based on platinum that has applications in
the effective management of ovarian, testis, cervical, neck, head, and small cell lung cancer …

Drug loading and functional efficacy of cow, buffalo, and goat milk-derived exosomes: a comparative study

F Ahmed, M Tamma, U Pathigadapa… - Molecular …, 2022 - ACS Publications
Quite recently, milk exosomes have been recognized as efficient drug delivery systems
owing to their biocompatibility and easy availability for scale-up technologies. However …

Nanomedicines for pediatric cancers

C Rodriguez-Nogales, Y Gonzalez-Fernandez… - ACS …, 2018 - ACS Publications
Chemotherapy protocols for childhood cancers are still problematic due to the high toxicity
associated with chemotherapeutic agents and incorrect dosing regimens extrapolated from …

Carboplatin-and etoposide-loaded lactoferrin protein nanoparticles for targeting cancer stem cells in retinoblastoma in vitro

RVL Narayana, P Jana, N Tomar… - … & Visual Science, 2021 - iovs.arvojournals.org
Purpose: Cancer stem cells (CSCs) are known to contribute to tumor relapses by virtue of
their chemoresistance. With the knowledge that nanoformulations can overcome drug …

Pediatric drug development: reviewing challenges and opportunities by tracking innovative therapies

C Domingues, I Jarak, F Veiga, M Dourado, A Figueiras - Pharmaceutics, 2023 - mdpi.com
The paradigm of pediatric drug development has been evolving in a “carrot-and-stick”-based
tactic to address population-specific issues. However, the off-label prescription of adult …

Development and in vitro evaluation of folate conjugated polydopamine modified carmustine-loaded liposomes for improved anticancer activity

SM Honmane, MS Charde, PB Choudhari… - Journal of Drug Delivery …, 2023 - Elsevier
Surface-modified, targeted nanocarriers play important roles in chemotherapy. The addition
of the ligand changes the chemical composition of the polymer; the ability to hold and …